- Withings Move ECG, the world’s first analog watch to record an electrocardiogram (ECG) on-demand, is now available in Europe, following CE marking for medical devices. - Move ECG syncs automatically with the accompanying Health Mate app, which instantaneously classifies the user’s heart rhythm as AFib or normal sinus rhythm. - Move ECG is available today at the price of €129.95/£129.95 at withings.com and main retail partners and works both on iOS and Android. Withings Move ECG,
Read More
iRhythm, Verily Collaborate to Develop Atrial Fibrillation Detection Solution
- iRhythm and Verily collaborate to develop health management solutions for atrial fibrillation patients.- The iRhythm and Verily collaboration aims to address this underserved population at risk for asymptomatic or silent AFib.- iRhythm will make an upfront payment to Verily of $5 million and potential milestone payments of up to $12.75 million.iRhythm Technologies, Inc. is teaming up with Verily, an Alphabet company focused on the development of digital health solutions aimed at improving the
Read More
How Tech Giants are Helping Providers Reinvent Patient Care
Healthcare costs are on the rise, and they show no signs of leveling off. According to the latest data available from the Centers for Medicare and Medicaid Services, healthcare spending in the United States reached $3.5 trillion in 2017, or $10,739 per person. Those costs are projected to rise by about five percent year-over-year.
As expenditures continue to skyrocket, healthcare providers are looking to new technologies and care strategies that can help them treat patients more effectively at a
Read More
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights. What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a similar long-term objective—capturing critical data to improve outcomes. “People want to
Read More
Philips, Medtronic Partner to Advance The Image-Guided Treatment of Atrial Fibrillation
Royal Philips has announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures.Impact of Atrial FibrillationAtrial fibrillation (AF) affects more than 33 million people worldwide. Cryoballoon ablation is used in a minimally invasive
Read More
Cardiogram’s Wearable Based Monitoring Tool Is Now Covered by Oscar
Cardiogram is a digital health company announced that it's wearable-based monitoring for atrial fibrillation and diabetes is now covered by Oscar Health Insurance, without paying out of pocket. The coverage will help provide end-to-end preventive care: continuous wearable monitoring, convenient testing, contextualized results, and clinical triage.Impact of Chronic ConditionsFor chronic conditions like diabetes, atrial fibrillation, hypertension, and sleep apnea, anywhere between 20–80% of cases
Read More
5 Groundbreaking Findings from the Stanford and Apple Heart Study
Stanford Medicine researchers recently released preliminary results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months.
Apple Heart Study Overview
Presented at American College of Cardiology’s 68th Annual Scientific Session and Expo in New Orleans, the study was launched in 2017 to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart's rhythm in the
Read More
Apple, Stanford Launches Heart Study App to Identify Irregular Heart Rhythms
Apple in partnership with Stanford Medicine has announced the launch of the Apple Heart Study app, a first-of-its-kind innovative research study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and notify users who may be experiencing atrial fibrillation (AFib). The Apple Heart Study app uses this technology to identify an irregular heart rhythm.Atrial Fibrillation (AFib), is the most common heart arrhythmia, and a leading cause of stroke. AFib affects more than
Read More
Medical Device Company BioSig Lands 10-Year with Strategic Partnership with Mayo Clinic
Medical device company BioSig has inked a 10-year strategic partnership with Mayo Clinic and Mayo Clinic Ventures. The expanded par expanded collaboration with Mayo builds upon the work realized under the Advanced Clinical Research Program that was signed with Mayo Clinic in March 2016.Partnership DetailsAs part of 10-year agreement, BioSig and Mayo will be developing advanced clinical features and applications for the company’s PURE EP System, which is addressing an unmet technology need for
Read More
